SEATTLE, WA / ACCESSWIRE / January 13, 2025 / 1606 Corp. (OTC Pink:CBDW) is excited to express its strong support for strategic investment target Adnexus Biotechnologies Inc. following the company's ...
The World Health Organization (WHO) has approved a diagnostic test for glucose-6-phosphate dehydrogenase (G6PD) deficiency, a genetic condition that can affect malaria treatment. This test will help ...